Ticker

PEKIN, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its fourth quarter and year-end 2025 financial results after the close of market on Wednesday, March 4, 2026.

Alto Ingredients (NASDAQ: ALTO - Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, March 4th. Analysts expect Alto Ingredients to post earnings of $0.02 per share and revenue of $234.83 million for the quarter. Parties may visit the the company's upcoming Q4 2025 earning results page

Alto Ingredients, Inc. (NASDAQ: ALTO - Get Free Report) dropped 5.2% during trading on Tuesday. The stock traded as low as $2.52 and last traded at $2.54. Approximately 556,388 shares changed hands during trading, a decline of 33% from the average daily volume of 824,512 shares. The stock had previously closed at $2.68. Wall Street

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the completion of patient enrollment in its Phase 2 proof-of-concept clinical trial evaluating ALTO-101, a novel, transdermal phosphodiesterase-4 (PDE4) inhibitor, for…

Alto Ingredients (ALTO) has transitioned from a pure ethanol producer to a diversified, higher-margin specialty ingredients and CO₂ business. Q3 results confirm a structural earnings inflection, with GAAP profitability, improved product mix, and cost discipline driving sustainable margin expansion. Section 45Z tax credits, effective 2026, will materially reset ALTO's earnings floor, providing multi-year regulatory…